跳到正文
原文
MedPage Today·· 10 天前AI 评分60

糖尿病学会出版负责人辞职

ADA Publications Chief Resigns

AI 导读

糖尿病学会的出版负责人 Christian Kohler 因编辑部内部的争议辞职,表达了对临时编辑安排的担忧,认为这将损害期刊的信誉。学会回应称临时编辑团队由经验丰富的专业人士组成,并表示正在与抵制活动的领导者会面以解决问题。

正文

— The plan for the organization's key journal amid the ongoing boycott is a concern, he says

by Kristina Fiore, Director of Enterprise & Investigative Reporting, MedPage Today

November 10, 2026 • 3 min read

The vice president of publications at the American Diabetes Association (ADA) has resigned amid the ongoing boycott of the organization.

Christian Kohler, who was with the ADA for 22 years, expressed "profound disappointment" at the overall handling of events at this year's annual meeting in New Orleans, but said in his resignation letter that his "immediate decision" to leave was tied to what's happening at the ADA's flagship journal Diabetes Care.

That includes ADA attempting to bring in interim editors while the majority of the journal's staff participates in the boycott.

"Throughout my nearly three decades in scientific and medical publishing, I have worked to uphold the principles of editorial independence, scientific integrity, transparency, and accountability," Kohler wrote. "Based on that experience, I believe the proposed interim editorial arrangement presents serious ethical, operational, and reputational risks."

In particular, Kohler said he's concerned about how interim staff brought in during the boycott have to perform their duties without an editor in chief who assumes ultimate responsibility for everything in the journal. The absence of a formal process to evaluate interim editors' "suitability for handling the breadth and complexity of research" submitted to the journal is also "problematic," he noted in his letter.

He said he also believes these interim editors are "being placed in an untenable position, one in which their ability to succeed will be severely constrained by circumstances beyond their control, potentially placing their own professional reputations at risk."

The approach to bring in interim editors won't restore confidence in the publication, Kohler added.

"To be clear, I fear it will further undermine the credibility, integrity, and international reputation of Diabetes Care, a journal whose standing has been built over decades through the contributions of dedicated editors, reviewers, authors, and ADA publications staff," he wrote.

In an emailed statement to MedPage Today, the ADA defended its actions on Diabetes Care, noting that its interim editorial board consists of "highly experienced and respected healthcare professionals who have dedicated their careers to caring for people living with diabetes, including endocrinologists, primary care physicians focused on diabetes care, diabetes educators, and more."

ADA added that it is in "conversations with some of the people leading the boycott to schedule a meeting," and that it previously outlined the "next steps that we plan to take to learn and improve based on the facts that came to bear from the review."

Many have criticized the organization's final report on what happened at the annual meeting, taking issue with what it described as perceived threats to "disrupt and protest" the event. That final report also said ADA members who were kicked out of the meeting did not violate its code of conduct, a reversal from an earlier version of the report.

The ADA has lost several leaders in the wake of the annual meeting; Chief Science and Medical Officer Rita Kalyani, MD, and ADA Board Chair James Tai left just before the final report came out. Other resignations came soon after the five researchers were booted from the meeting, including Scientific Sessions Planning Committee Chair Mark Atkinson, PhD, and President-Elect Jennifer Green, MD.

Kohler also said the ADA hasn't yet meaningfully addressed the concerns raised by more than 1,200 people participating in the boycott, which launched in September.

"This is not a frivolous exercise for the boycotters," Kohler told MedPage Today, noting that many of them have spent decades volunteering for ADA programs.

"These are the people ... that ADA leadership should be engaging with most closely to confront the challenges faced by people with diabetes and the scientific and medical communities," he said. "That's not happening."

As the ADA "tries to outrun this storm," he added, it's "missing an opportunity to work with and support the professional community on so many urgent, critical issues."

"My sincere hope is that my letter will play some small role in facilitating a discussion and real action that resolves the boycott," he noted. "I, too, invested a lot in the organization over the years, and I also care deeply about its mission."

Kohler said his resignation would be effective Nov. 30.

来源:MedPage Today · medpagetoday.com